Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
34.6M
-
Shares change
-
+3.13M
-
Total reported value, excl. options
-
$391M
-
Value change
-
+$35.5M
-
Number of buys
-
25
-
Number of sells
-
-6
-
Price
-
$11.32
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q1 2023
37 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q1 2023.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.6M shares
of 130M outstanding shares and own 26.63% of the company stock.
Largest 10 shareholders include Social Capital Group LLC (13.3M shares), MORGAN STANLEY (9.61M shares), VANGUARD GROUP INC (4.16M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.19M shares), Bleichroeder LP (2M shares), Brown University (1M shares), BlackRock Inc. (308K shares), BANK OF AMERICA CORP /DE/ (265K shares), GEODE CAPITAL MANAGEMENT, LLC (138K shares), and MILLENNIUM MANAGEMENT LLC (102K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.